The pharmaceutical landscape is currently undergoing a significant shift toward automated and AI-driven safety monitoring to manage the increasing volume of adverse event reports. The Drug Safety Solutions & Pharmacovigilance Market was valued at USD 13,242.32 billion in 2024 and is projected to reach USD 23,442.20 billion by 2032, expanding at a CAGR of...

The increasing complexity of drug development and the surge in adverse event reports are driving a fundamental shift toward automated safety monitoring. The Drug Safety Solutions & Pharmacovigilance Market was valued at USD 13,242.32 billion in 2024 and is projected to reach USD 23,442.20 billion by 2032, growing at a CAGR of 9.61% during the forecast...